Ra Capital Nexus Fund Ii, L.p. - Net Worth and Insider Trading

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .

In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.

Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in DICE Therapeutics Inc (DICE). Other recent insider transactions involving DICE Therapeutics Inc (DICE) include a net sale of 2,492,871 shares made by Northpond Ventures Gp, Llc , and a net sale of 18,750 shares made by John R. Jacobsen .

In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,511,621 shares of DICE Therapeutics Inc (DICE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,511,621 shares.

DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Climb Bio Inc (CLYM). Other recent insider transactions involving Climb Bio Inc (CLYM) include a net sale of 481,639 shares made by Valerie Morisset , a net sale of 2,436 shares made by Emily Pimblett , and a net purchase of 13,008,546 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 1,191 shares of Climb Bio Inc (CLYM) in total and bought 0 shares, with a net sale of 1,191 shares. During the past 18 months, 484,075 shares of Climb Bio Inc (CLYM) were sold and 13,008,546 shares were bought by its insiders, resulting in a net purchase of 12,524,471 shares.

Climb Bio Inc (CLYM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 193,993 shares made by Adam K. Simpson , a net sale of 28,581 shares made by Cassia Cearley , and a net sale of 18,249 shares made by Thomas Joseph Russo .

In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 272,386 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 272,386 shares.

Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Cytek Biosciences Inc (CTKB). Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net sale of 221,900 shares made by Ming Yan , a net sale of 24,000 shares made by Patrick Jeanmonod , and a net sale of 120,000 shares made by Wenbin Jiang .

In summary, during the past 3 months, insiders sold 0 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 365,900 shares of Cytek Biosciences Inc (CTKB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 365,900 shares.

Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 50,000 shares made by Michelle L Mellion , a net sale of 29,556 shares made by James G Mcarthur , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc (PEPG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 91,250 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,468,037 shares.

PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , a net sale of 223,880 shares made by Kabeer Aziz , and a net sale of 1,747,316 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 1,500,000 shares, with a net purchase of 1,500,000 shares. During the past 18 months, 4,090,725 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,287,778 shares were bought by its insiders, resulting in a net sale of 802,947 shares.

AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net sale of 7,965 shares made by Chione Ltd , and a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd .

In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 2,353,000 shares were bought by its insiders, resulting in a net purchase of 2,345,035 shares.

Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 1,603,260 shares made by Sarina Tanimoto , a net sale of 1,603,260 shares made by Richard E Lowenthal , and a net sale of 400,000 shares made by Laura Shawver .

In summary, during the past 3 months, insiders sold 2,999,754 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 2,999,754 shares. During the past 18 months, 5,636,274 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,937,557 shares were bought by its insiders, resulting in a net purchase of 3,301,283 shares.

ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 3,324,326 shares made by Avalon Ventures Xi, L.p. , a net sale of 653,961 shares made by Jay Lichter , and a net purchase of 1,695,008 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 2,782,995 shares of Janux Therapeutics Inc (JANX) in total and bought 1,200,000 shares, with a net sale of 1,582,995 shares. During the past 18 months, 6,605,716 shares of Janux Therapeutics Inc (JANX) were sold and 4,244,570 shares were bought by its insiders, resulting in a net sale of 2,361,146 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.